PROJECT

Projects

Environmental & Social Review Summary

Project Number

45065

Company Name

STEIN HOLDING GROUP LLC

Date ESRS Disclosed

Nov 5, 2021

Country

Costa Rica

Region

Latin America and the Caribbean

Last Updated Date

May 21, 2023

Environmental Category

B - Limited

Status

Active

Previous Events

Approved : May 26, 2022
Signed : Jun 30, 2022
Invested : May 19, 2023

Sector

other

Industry

other

Department

Regional Industry MAS LAC & EUR

Project Description

Stein Cares (“Stein” or the “company”) is a regional market leader in specialty pharmaceutical care products with 40 years of experience and a presence in Central America, the Caribbean and South America. Company’s revenues are geographically distributed being Costa Rica the highest one, followed by Ecuador, Panama, Guatemala and the rest of Latin America (LAC). Stein has a diversified product portfolio that includes innovative drugs, biosimilars, orphan drugs and high-quality generics.  Stein has a manufacturing plant in Cartago, Costa Rica (https://goo.gl/maps/PTHBSu21bFoRV4zG8), which was renovated in 2018 and is dedicated to the production of finished dosage forms of several high-quality generics including medicines to treat infections, high-blood pressure, diabetes and neuropsychiatric symptoms. The rest of the company’s product portfolio is developed and supplied by biopharmaceuticals and 20 world class manufactures worldwide who also supply markets in the United States and European Union.  Stein has its own distribution center adjacent to its manufacturing plant in Costa Rica and relies on third-party logistics (3PL) services in other countries for the distribution of product.  The proposed IFC financing is a $24 million equity investment in the company to finance its strategic expansion plan in Latin America and the Caribbean focused on the growth of high-specialty products (biosimilars, innovative, orphan drugs) through new licensing agreements and inorganic growth strategies.                                                   

Overview of IFC's Scope of Review

Given current travel restrictions related to the COVID-19 pandemic, IFC’s Environmental and Social Due Diligence consisted of a virtual appraisal comprising a review of technical, environmental, and social information made available by the company as well as video conference meetings, photographic evidence and videos of the manufacutirng facility including the raw materials warehouse, laboratories, production areas, flammables storage area, temporary waste storage area and distribution center. During the meetings, company representatives responsible for environmental, health, safety, quality control, and human resources, explained the main environmental and social (E&S) aspects associated with the company’s operations and the existing mitigation measures. Presentations included an overview of the organizational structure, associated competency and relevant management systems. The appraisal will be supplemented with a field review after COVID-19 related travel restrictions are removed and this Environmental and Social Review Summary document and the companion E&S Action Plan (ESAP) will be updated accordingly if needed.             

E & S Project Categorization and Applicable Standard

Environmental and Social Mitigation Measures

Stakeholder Engagement

Broad Community Support

Environmental & Social Action Plan